The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review

PloS One
Jan GaertnerNorbert Schmacke

Abstract

Randomized controlled trials (RCTs) are important sources of information on the benefits and harms patients may expect from treatment options. The aim of this structured literature review by the German Institute for Quality and Efficiency in Health Care was to explore whether and how the end-of-life (EoL) situation of patients with advanced cancer is considered in RCTs investigating anti-cancer treatments. Our journal pool comprised 19 medical journals, namely five preselected key general medical journals as well as 14 specialist journals (mainly cancer) identified via a scoping search. We systematically searched these journals in MEDLINE to identify RCTs investigating anti-cancer treatments for the following four cancer types: glioblastoma, lung cancer (stage IIIb-IV), malignant melanoma (stage IV), and pancreatic cancer (search via OVID; November 2012). We selected a representative sample of 100 publications, that is, the 25 most recent publications for each cancer type. EoL was defined as a life expectancy of ≤ two years. We assessed the information provided on (1) the descriptions of the terminal stage of the disease, (2) the therapeutic goal (i.e. the intended therapeutic benefit of the intervention studied), (3) the study...Continue Reading

References

Nov 17, 2004·Annals of Internal Medicine·John P A IoannidisUNKNOWN CONSORT Group
Apr 30, 2005·BMJ : British Medical Journal·Scott A MurrayAziz Sheikh
May 19, 2007·Journal of Pain and Symptom Management·Saskia C C M TeunissenAlexander de Graeff
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm RansonMark R Middleton
Nov 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathleen GondekJ Michael Woolley
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David F McDermottEvan Hersh
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A ReardonL Burt Nabors
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Aug 6, 2009·British Journal of Cancer·K RainbirdP Anseline
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickHoward A Fine
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe ColucciUNKNOWN Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
Mar 25, 2010·BMJ : British Medical Journal·David MoherDouglas G Altman
May 14, 2010·Japanese Journal of Clinical Oncology·Yousuke NakaiKazuhiko Koike
May 24, 2011·Seminars in Oncology·Nathan Cherny
Nov 15, 2011·Lancet·Melanie CalvertMichael Brundage
Feb 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJamie H Von Roenn
Feb 9, 2012·Annals of Internal Medicine·Keith M Swetz, Arif H Kamal
May 23, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Roger StuppPhilip H Gutin
Aug 28, 2012·Medical Care·Sara AhmedUNKNOWN International Society for Quality of Life Research
Aug 30, 2012·Cancer·Charles S CleelandUNKNOWN CPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force
Oct 12, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·Michael H LevyUNKNOWN NCCN (National Comprehensive Cancer Network)
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschSean Tunis
Jan 5, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Bryce B ReeveZeeshan Butt
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Melanie CalvertUNKNOWN CONSORT PRO Group
Apr 9, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shrividya IyerAdam Roughley
Jun 26, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Donald Patrick
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Brian S SealPamela D Allen
Sep 13, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shrividya IyerGavin Taylor-Stokes
Dec 3, 2013·International Journal of Technology Assessment in Health Care·Michael D Rawlins

❮ Previous
Next ❯

Citations

Mar 10, 2016·Expert Review of Clinical Pharmacology·V WeingärtnerJ Gaertner
Jul 10, 2012·Magnetic Resonance Imaging·Andriy FedorovRon Kikinis
May 10, 2016·Nature Reviews. Disease Primers·Jorg KleeffJohn P Neoptolemos
Apr 24, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Matjaz Zwitter

❮ Previous
Next ❯

Software Mentioned

OVID
CONSORT

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Simone Mathoulin-PelissierAndrew Kramar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lily ClaassensA Bottomley
© 2021 Meta ULC. All rights reserved